Jianxiang Chen

9PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2026
RNA splicing in cancer cell death regulation: shedding light on the molecular mechanisms and potential clinical applications.

|Jan 12, 2026
Elemene Augments the Effects of Anti-PD-1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR-130a-5p/SPP/MHC-I Axis.

Menglan Wang, Mengqing Sun, Heng Dong

|Sep 24, 2025
N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.

Qian Li, Xu Huang, Yan Tong

|Jul 17, 2024
Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma.

Cunjie Chang, Lina Li, Ling Su

|Nov 13, 2023
Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma.

Qian Li, Mengqing Sun, Yao Meng

|Mar 17, 2022
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao

Pageof 2

Frequent Collaborators

4 joint publications

Qian Li

2 joint publications

Kam Man Hui

2 joint publications

Liang Xu

2 joint publications

Ye Chen